HealthDay - WEDNESDAY, Dec. 22 (HealthDay News) -- U.S. Food and Drug Administration approval of Gardasil (human papillomavirus vaccine) has been widened to include prevention of anal cancer and associated precancerous lesions, the agency said Wednesday in a news release.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.